MAPS | Research > Medical Marijuana

MAPS is currently seeking regulatory approval to conduct a study of smoked and/or vaporized marijuana for symptoms of PTSD in veterans of war.

MAPS is the only organization working to demonstrate the safety and efficacy of botanical marijuana as a prescription medicine for specific medical uses to the satisfaction of the U.S. Food and Drug Administration.

Our efforts to initiate medical marijuana research have been hindered by the National Institute on Drug Abuse (NIDA) and the Drug Enforcement Administration (DEA) since our founding in 1986. NIDA’s monopoly on the supply of marijuana for research and the DEA’s refusal to allow researchers to grow their own has paralyzed medical marijuana research, and for over ten years MAPS has been involved in legal struggles against the DEA to end this situation.

Watch The Science and Politics of Medical Marijuana workshop from MAPS’ 25th anniversary conference, led by top experts in medical marijuana research and advocacy.

See below for frequently updated information about completed, ongoing, or planned MAPS studies, as well as details of our ongoing DEA lawsuit.

Explore MAPS in the Media for media coverage of MAPS projects.











More stuff…

Featured Material


  1. No trackbacks yet.

You must be logged in to post a comment.
%d bloggers like this: